Structures by: Suckling C. J.
Total: 18
C12H20N5O4PS
C12H20N5O4PS
Organic & Biomolecular Chemistry (2009) 7, 1 178-186
a=18.0006(6)Å b=10.8282(3)Å c=25.5950(9)Å
α=90.00° β=98.184(2)° γ=90.00°
C16.8H19.2N4O4.8
C16.8H19.2N4O4.8
Organic & Biomolecular Chemistry (2009) 7, 9 1829-1842
a=7.1471(3)Å b=10.1809(4)Å c=12.3149(5)Å
α=81.282(3)° β=77.534(2)° γ=81.436(3)°
Ethyl 4-nitro-1<i>H</i>-pyrrole-2-carboxylate
C7H8N2O4
Acta Crystallographica Section E (2017) 73, 2 254-259
a=11.0318(13)Å b=10.4108(13)Å c=7.1659(8)Å
α=90.00° β=96.734(10)° γ=90.00°
Ethyl 4-nitro-1-(4-pentynyl)-1<i>H</i>-pyrrole-2-carboxylate
C12H14N2O4
Acta Crystallographica Section E (2017) 73, 2 254-259
a=7.8839(4)Å b=16.1443(7)Å c=10.2058(5)Å
α=90.00° β=104.472(5)° γ=90.00°
<i>N</i>-[3-(Dimethylamino)propyl]-1-isopentyl-4-nitro-1<i>H</i>-pyrrole-2-carboxamide
C15H26N4O3
Acta Crystallographica Section E (2017) 73, 2 254-259
a=17.5744(7)Å b=11.3718(6)Å c=8.7299(4)Å
α=90.00° β=92.076(4)° γ=90.00°
1-(3-Azidopropyl)-4-(1-methyl-4-nitro-1<i>H</i>-pyrrole-2-carboxamido)-<i>N</i>-[2-(morpholin-4-yl)ethyl]-1<i>H</i>-pyrrole-2-carboxamide
C20H27N9O5
Acta Crystallographica Section E (2017) 73, 2 254-259
a=11.2809(4)Å b=16.4528(6)Å c=12.5130(5)Å
α=90.00° β=106.542(4)° γ=90.00°
<i>N</i>,<i>N</i>-Dimethyl-2-[(4-methylbenzyl)sulfonyl]ethanamine
C12H19NO2S
Acta Crystallographica Section E (2015) 71, 7 757-759
a=5.3642(3)Å b=10.3773(6)Å c=12.1784(7)Å
α=99.572(5)° β=95.498(5)° γ=104.645(5)°
2-(1-Piperidinyl)-1,3-benzothiazole
C12H14N2S
Acta Crystallographica Section E (2005) 61, 3 o569-o570
a=15.3509(6)Å b=11.6315(4)Å c=5.9802(2)Å
α=90.00° β=90.00° γ=90.00°
NH4O1,C6H6NO41
NH4O1,C6H6NO41
Acta Crystallographica Section E (2003) 59, 9 o1410-o1412
a=4.6788(2)Å b=13.3277(6)Å c=13.5380(7)Å
α=90.00° β=97.212(2)° γ=90.00°
Methyl 2-amino-5-isopropyl-1,3-thiazole-4-carboxylate
C8H12N2O2S
Acta Crystallographica Section E (2004) 60, 9 o1510-o1512
a=8.4219(13)Å b=9.9620(12)Å c=12.4307(15)Å
α=90° β=90.916(11)° γ=90°
3-Nitro-1-(triisopropylsilyl)-1H-pyrrole
C13H24N2O2Si
Acta Crystallographica Section E (2006) 62, 8 o3282-o3284
a=9.6924(5)Å b=15.9437(10)Å c=10.1267(6)Å
α=90.00° β=95.089(4)° γ=90.00°
Ethyl 2-aminooxazole-5-carboxylate
C6H8N2O3
Acta Crystallographica Section E (2001) 57, 9 o832-o833
a=6.1295(6)Å b=7.8227(6)Å c=8.3961(8)Å
α=113.592(7)° β=93.831(4)° γ=95.557(4)°
C9H14N2O2S
C9H14N2O2S
Acta Crystallographica Section E (2004) 60, 7 o1188-o1190
a=7.8757(10)Å b=9.1080(11)Å c=15.8434(12)Å
α=90.00° β=100.853(9)° γ=90.00°
Ethyl 2-({6-amino-2-(benzylsulfanyl)-5-[2-(ethoxycarbonyl)prop-2-enyl]pyrimidin- 4-yloxy}methyl)acrylate
C23H27N3O5S
Acta Crystallographica Section E (2006) 62, 1 o324-o326
a=7.3668(2)Å b=11.5842(3)Å c=14.5700(4)Å
α=111.692(2)° β=99.520(2)° γ=93.076(2)°
C7H10N2O3S
C7H10N2O3S
Acta Crystallographica Section C (1999) 55, 7 IUC9900072
a=7.5544(17)Å b=8.5939(12)Å c=14.489(2)Å
α=77.136(11)° β=86.800(15)° γ=88.879(16)°
Cholest-5-enyl-3β,4β-diacetate
C31H50O4
Acta Crystallographica Section C (1999) 55, 9 1570-1572
a=6.293(3)Å b=10.255(2)Å c=22.172(5)Å
α=90.00° β=96.17(3)° γ=90.00°
C10H10O5
C10H10O5
Acta Crystallographica Section C (2000) 56, 6 e265-e266
a=10.4676(18)Å b=10.4774(15)Å c=10.5727(18)Å
α=71.878(12)° β=64.619(12)° γ=69.533(12)°
2,2,2-Trifluoro-<i>N</i>-(isoquinolin-5-ylmethyl)acetamide
C12H9F3N2O
Acta Crystallographica Section E (2010) 66, 1 o135
a=7.2308(7)Å b=8.3498(11)Å c=18.157(2)Å
α=90° β=90.583(9)° γ=90°